BAP1 and pancreatic adenocarcinoma: Notably, genomic losses of BAP1 were mainly present in high-purity samples (p = 0.0178; two-sided Fisher’s exact test), indicating that the frequency and depth of deletion may be underestimated in the TCGA-PAAD cohort (Supplementary Fig. 1a).